glp receptor 1 agonists GLP1 Agonists—Effects beyond Obesity and Diabetes Glucagon-like peptide 1 receptor agonists:
Description
Switching between GLP-1 medications There are a few reasons why your clinician may suggest switching GLP-1s
Findings from a large multicenter analysis of more than 1.5 million adults with type 2 diabetes in six national health databases were in line with these results
Day JW, Ottaway N, Patterson JT, Gelfanov V, Smiley D, Gidda J, et al
Similar findings were identified in comparison with metformin (HR, 0.75
United States: Kaiser Family Foundation
doi: 10.1016/j.jacc.2024.05.057
